688581 Stock Overview
Engages in the research, development, production, sale, and service of endoscopic surgery equipment and accessories in China. More details
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 4/6 |
| Past Performance | 5/6 |
| Financial Health | 6/6 |
| Dividends | 3/6 |
Rewards
Risk Analysis
No risks detected for 688581 from our risk checks.
My Notes
Capture your thoughts, links and company narrative
Hangzhou AGS MedTech Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥60.71 |
| 52 Week High | CN¥91.76 |
| 52 Week Low | CN¥42.92 |
| Beta | 0 |
| 1 Month Change | -5.05% |
| 3 Month Change | -4.71% |
| 1 Year Change | -31.90% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -31.62% |
Recent News & Updates
Recent updates
An Intrinsic Calculation For Hangzhou AGS MedTech Co., Ltd. (SHSE:688581) Suggests It's 43% Undervalued
Oct 25
There May Be Underlying Issues With The Quality Of HangzhouS MedTech's (SHSE:688581) Earnings
Apr 29Hangzhou AGS MedTech Co., Ltd. (SHSE:688581) Looks Inexpensive But Perhaps Not Attractive Enough
Apr 24Shareholder Returns
| 688581 | CN Medical Equipment | CN Market | |
|---|---|---|---|
| 7D | -0.8% | 0.2% | -0.6% |
| 1Y | -31.9% | -11.6% | 8.3% |
Return vs Industry: 688581 underperformed the CN Medical Equipment industry which returned -11.6% over the past year.
Return vs Market: 688581 underperformed the CN Market which returned 8.3% over the past year.
Price Volatility
| 688581 volatility | |
|---|---|
| 688581 Average Weekly Movement | 6.1% |
| Medical Equipment Industry Average Movement | 8.3% |
| Market Average Movement | 8.7% |
| 10% most volatile stocks in CN Market | 12.9% |
| 10% least volatile stocks in CN Market | 5.6% |
Stable Share Price: 688581 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 688581's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2010 | 672 | Cheng Zhang | www.bioags.com |
Hangzhou AGS MedTech Co., Ltd. engages in the research, development, production, sale, and service of endoscopic surgery equipment and accessories in China. It offers hemoclips; bipolar generators, CR4500 CO2 regulation units, and UW600-II water pumps; disposable stone extraction baskets, nasal biliary drainage catheters, sphincterotomes, disposable guide wires, and stone retrieval balloons; disposable bipolar ESD knives, polypectomy snares, and disposable sclerotherapy needles; and disposable grasping forceps and disposable biopsy forceps. The company was founded in 2010 and is based in China.
Hangzhou AGS MedTech Co., Ltd. Fundamentals Summary
| 688581 fundamental statistics | |
|---|---|
| Market cap | CN¥4.88b |
| Earnings (TTM) | CN¥271.52m |
| Revenue (TTM) | CN¥590.12m |
18.0x
P/E Ratio8.3x
P/S RatioIs 688581 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 688581 income statement (TTM) | |
|---|---|
| Revenue | CN¥590.12m |
| Cost of Revenue | CN¥162.79m |
| Gross Profit | CN¥427.34m |
| Other Expenses | CN¥155.82m |
| Earnings | CN¥271.52m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
Apr 23, 2025
| Earnings per share (EPS) | 3.37 |
| Gross Margin | 72.41% |
| Net Profit Margin | 46.01% |
| Debt/Equity Ratio | 0% |
How did 688581 perform over the long term?
See historical performance and comparisonDividends
1.7%
Current Dividend Yield31%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/30 19:49 |
| End of Day Share Price | 2024/12/30 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Hangzhou AGS MedTech Co., Ltd. is covered by 2 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Shuo Song | Citic Securities Co., Ltd. |
| Yin Ye | Ping An Securities Co. Ltd. |